Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)

被引：0
作者：
Luisa Klotz
Berit Grützke
Maria Eveslage
Michael Deppe
Catharina C. Gross
Lucienne Kirstein
Anita Posevitz-Fejfar
Tilman Schneider-Hohendorf
Nicholas Schwab
Sven G. Meuth
Heinz Wiendl
机构：
[1] University Hospital Münster,Department of neurology
[2] Westfaelische Wilhelms-University Münster,Institute of biostatistics and clinical research
来源：
BMC Neurology | / 15卷
关键词：
Multiple sclerosis; Natalizumab; Fingolimod; PML; Switching;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 414 条
[41]  
Goelz SE(undefined)undefined undefined undefined undefined-undefined
[42]  
Subramanyam M(undefined)undefined undefined undefined undefined-undefined
[43]  
Bloomgren G(undefined)undefined undefined undefined undefined-undefined
[44]  
Richman S(undefined)undefined undefined undefined undefined-undefined
[45]  
Hotermans C(undefined)undefined undefined undefined undefined-undefined
[46]  
Subramanyam M(undefined)undefined undefined undefined undefined-undefined
[47]  
Goelz S(undefined)undefined undefined undefined undefined-undefined
[48]  
Natarajan A(undefined)undefined undefined undefined undefined-undefined
[49]  
Lee S(undefined)undefined undefined undefined undefined-undefined
[50]  
Plavina T(undefined)undefined undefined undefined undefined-undefined
12345678910